SCHEDULE 13G/A: Walleye Capital LLC Discloses 2.72% Beneficial Ownership in Envoy Medical Warrants

Walleye Capital LLC has filed an amended Schedule 13G, reporting a 2.72% beneficial ownership stake in Envoy Medical, Inc.'s redeemable warrants as of December 31, 2024.

Summary

• Walleye Capital LLC reported beneficial ownership of 566,735 redeemable warrants of Envoy Medical, Inc. as of December 31, 2024.
• These warrants are exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share.
• This ownership represents 2.72% of the total class of redeemable warrants.
• Walleye Capital LLC, identified as an investment adviser, holds sole voting and sole dispositive power over all 566,735 warrants.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported beneficial ownership position.

Sentiment

Score: 5

Explanation: Neutral. This document is a routine regulatory filing disclosing beneficial ownership and does not contain information related to company performance, strategic changes, or future outlook.

Positives

• The filing provides transparency regarding the beneficial ownership of Envoy Medical, Inc.'s redeemable warrants by Walleye Capital LLC, an institutional investment adviser.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding significant warrant holdings by an institutional investor, which can inform investment decisions.

Key Dates

Keywords

Envoy Medical Inc., Walleye Capital LLC, Schedule 13G, Beneficial Ownership, Redeemable Warrants, Class A Common Stock, Investment Adviser, SEC Filing, 29415V117